WELLINGTON MANAGEMENT GROUP LLP

CIK 0000902219

16 SPACs with a current declared position, filed between Nov 10, 2020 and Nov 8, 2024. 0 of them were re-affirmed in the last 12 months. The rest are the filer’s last word on a position, not proof it is still held: an amendment is only required on a material change, so a fund that sells below 5% may never file again.

This filer has not filed a Schedule 13 on any SPAC since Nov 8, 2024. Read the page below as a record of what was declared, not as a register of what is held.

Filed under 2 earlier names

WELLINGTON MANAGEMENT CO LLP · WELLINGTON MANAGEMENT COEDGAR’s own former-name record for CIK 0000902219. The page did not move when the filer renamed, because the identity is the CIK and the URL is a label it owns.

SPACs declared

every position whose latest statement stands — the record

Re-affirmed in 12 months

filed inside 365 days — what a reader means by "owns"

Still live

positions in SPACs still searching or in an announced deal

Median stake

7.8%

no percentage stated on the cover pages

16 passive (13G)97 superseded statements on file

Positions

one row per SPAC — every figure read from the accession in the Source column

16 of 16 shown · 16 positions have not been amended in over a year

	SPAC			Voting	Dispositive			Source
DBDR	Roman DBDR Tech Acquisition Corp.4 reporting persons on this schedule	12.9%	3,568,597	0 / 3,568,597	0 / 3,568,597	Closed (deSPAC)	Oct 4, 2024Stale	SC 13G/A0000902219-24-000335 3 earlier statements
HLAH	Hamilton Lane Alliance Holdings I, Inc.4 reporting persons on this schedule	11.6%	3,202,085	0 / 2,880,156	0 / 3,202,085	Liquidated	Feb 4, 2022Stale	SC 13G/A0001678858-22-000158 4 earlier statements
NMMC	North Mountain Merger Corp.4 reporting persons on this schedule	11.2%	1,477,350	0 / 1,477,350	0 / 1,477,350	Liquidated	Aug 10, 2022Stale	SC 13G/A0000902219-22-000046 11 earlier statements
DALS	DA32 Life Science Tech Acquisition Corp.4 reporting persons on this schedule	11.0%	2,826,091	0 / 2,826,091	0 / 2,826,091	Liquidated	Feb 10, 2022Stale	SC 13G/A0000902219-22-000014 7 earlier statements
CCXX	Butler Acquisition Corp4 reporting persons on this schedule	10.7%	14,643,100	0 / 12,795,825	0 / 14,643,100	Closed (deSPAC)	Nov 10, 2020Stale	SC 13G/A0000902219-20-000437 3 earlier statements
MILE	INSU Acquisition Corp. II4 reporting persons on this schedule	8.7%	2,039,730	0 / 1,930,527	0 / 2,039,730	Closed (deSPAC)	Feb 4, 2022Stale	SC 13G/A0001678858-22-000302 3 earlier statements
BOWX	BowX Acquisition Corp.4 reporting persons on this schedule	8.5%	4,113,923	0 / 4,034,123	0 / 4,113,923	Closed (deSPAC)	Feb 4, 2022Stale	SC 13G/A0001678858-22-000265 3 earlier statements
FTCV	Fintech Acquisition Corp V4 reporting persons on this schedule	8.1%	2,150,958	0 / 2,150,958	0 / 2,150,958	Liquidated	Feb 4, 2022Stale	SC 13G/A0001678858-22-000145 4 earlier statements
MTAC	MedTech Acquisition Corp4 reporting persons on this schedule	7.4%	1,847,443	0 / 1,847,443	0 / 1,847,443	Closed (deSPAC)	Feb 6, 2023Stale	SC 13G/A0000846087-23-000137 7 earlier statements
FTAA	FTAC Athena Acquisition Corp.4 reporting persons on this schedule	7.1%	1,818,457	0 / 1,818,457	0 / 1,818,457	Liquidated	Feb 6, 2023Stale	SC 13G/A0000846087-23-000050 4 earlier statements
FTVI	FINTECH ACQUISITION CORP VI4 reporting persons on this schedule	7.0%	1,800,000	0 / 1,800,000	0 / 1,800,000	Liquidated	Feb 4, 2022Stale	SC 13G0001678858-22-000146
SVFC	SVF Investment Corp. 34 reporting persons on this schedule	6.8%	2,230,872	0 / 1,923,645	0 / 2,230,872	Closed (deSPAC)	Feb 6, 2023Stale	SC 13G/A0000846087-23-000047 3 earlier statements
FSDC	FS Development Corp.4 reporting persons on this schedule	6.2%	1,840,226	0 / 1,477,701	0 / 1,840,226	Closed (deSPAC)	Nov 8, 2024Stale	SC 13G0000902219-24-000485 7 earlier statements
RACA	Therapeutics Acquisition Corp.4 reporting persons on this schedule	6.2%	868,340	0 / 853,705	0 / 868,340	Closed (deSPAC)	Feb 4, 2022Stale	SC 13G/A0001678858-22-000236 3 earlier statements
CORS	Corsair Partnering Corp4 reporting persons on this schedule	5.9%	1,662,726	0 / 1,662,726	0 / 1,662,726	Liquidated	Feb 6, 2023Stale	SC 13G/A0000846087-23-000046 4 earlier statements
FTIV	FinTech Acquisition Corp. IV4 reporting persons on this schedule	5.1%	2,123,469	0 / 1,833,168	0 / 2,123,469	Closed (deSPAC)	Feb 8, 2024Stale	SC 13G/A0000902219-24-000111 31 earlier statements

97 superseded statements (newest 27 shown)

An amendment replaces a stake as current; it never erases the record of it. These are the earlier statements, each with the accession that replaced it — kept because “what did this filer say in 2022” is a different question from “what does it say now”, and only the second one has an answer above.

DBDR Roman DBDR Tech Acquisition Corp.12.9% · SC 13G Jun 6, 2024replaced Oct 4, 2024 by 0000902219-24-000335
FTIV FinTech Acquisition Corp. IV5.1% · SC 13G/A Sep 8, 2023replaced Feb 8, 2024 by 0000902219-24-000111
FTIV FinTech Acquisition Corp. IV11.1% · SC 13G/A Feb 6, 2023replaced Sep 8, 2023 by 0000902219-23-000045
FTIV FinTech Acquisition Corp. IV12.0% · SC 13G/A Nov 10, 2022replaced Feb 6, 2023 by 0000846087-23-000156
FTIV FinTech Acquisition Corp. IV17.7% · SC 13G/A May 9, 2022replaced Nov 10, 2022 by 0000902219-22-000066
NMMC North Mountain Merger Corp.11.2% · SC 13G/A Feb 10, 2022replaced Aug 10, 2022 by 0000902219-22-000046
CORS Corsair Partnering Corp7.4% · SC 13G Feb 7, 2022replaced Feb 6, 2023 by 0000846087-23-000046
SVFC SVF Investment Corp. 37.3% · SC 13G Feb 4, 2022replaced Feb 6, 2023 by 0000846087-23-000047
FSDC FS Development Corp.0.0% · SC 13G/A Feb 4, 2022replaced Nov 8, 2024 by 0000902219-24-000485
FTIV FinTech Acquisition Corp. IV12.2% · SC 13G/A Feb 4, 2022replaced May 9, 2022 by 0000902219-22-000036
DALS DA32 Life Science Tech Acquisition Corp.11.2% · SC 13G/A Feb 4, 2022replaced Feb 10, 2022 by 0000902219-22-000014
MTAC MedTech Acquisition Corp7.4% · SC 13G/A Feb 4, 2022replaced Feb 6, 2023 by 0000846087-23-000137
FTAA FTAC Athena Acquisition Corp.7.3% · SC 13G Feb 4, 2022replaced Feb 6, 2023 by 0000846087-23-000050
NMMC North Mountain Merger Corp.9.5% · SC 13G Feb 4, 2022replaced Feb 10, 2022 by 0000902219-22-000017
DALS DA32 Life Science Tech Acquisition Corp.12.1% · SC 13G Aug 10, 2021replaced Feb 4, 2022 by 0001678858-22-000132
FTIV FinTech Acquisition Corp. IV11.8% · SC 13G Jul 12, 2021replaced Feb 4, 2022 by 0001678858-22-000207
FTIV FinTech Acquisition Corp. IV5.6% · SC 13G Mar 26, 2021replaced Mar 26, 2021 by 0000902219-21-000347
FTIV FinTech Acquisition Corp. IV10.5% · SC 13G Mar 26, 2021replaced Jul 12, 2021 by 0000902219-21-000374
HLAH Hamilton Lane Alliance Holdings I, Inc.12.8% · SC 13G Feb 10, 2021replaced Feb 4, 2022 by 0001678858-22-000158
FSDC FS Development Corp.7.9% · SC 13G Feb 4, 2021replaced Feb 4, 2022 by 0001678858-22-000283
RACA Therapeutics Acquisition Corp.6.3% · SC 13G Feb 4, 2021replaced Feb 4, 2022 by 0001678858-22-000236
MTAC MedTech Acquisition Corp7.8% · SC 13G Feb 4, 2021replaced Feb 4, 2022 by 0001678858-22-000182
NMMC North Mountain Merger Corp.8.6% · SC 13G Feb 4, 2021replaced Feb 4, 2022 by 0001678858-22-000323
BOWX BowX Acquisition Corp.8.7% · SC 13G Feb 4, 2021replaced Feb 4, 2022 by 0001678858-22-000265
MILE INSU Acquisition Corp. II8.9% · SC 13G Feb 4, 2021replaced Feb 4, 2022 by 0001678858-22-000302
FTCV Fintech Acquisition Corp V7.2% · SC 13G Feb 3, 2021replaced Feb 4, 2022 by 0001678858-22-000145
CCXX Butler Acquisition Corp10.8% · SC 13G Aug 10, 2020replaced Nov 10, 2020 by 0000902219-20-000437

Reporting persons on this filer's schedules

one filer, several names — collapsed once, shown in full

A joint Schedule 13 names every person who beneficially owns the shares — the management company, the funds it advises, the general partner and often the individual who controls all three. They report the same shares. Counting them separately would publish this filer’s footprint two or three times over, so they are counted once, under CIK 0000902219. This filer has named 4 of them across the schedules in the table above:

Wellington Group Holdings
Wellington Investment Advisors Holdings
Wellington Management
Wellington Management Group

Appears alongside

other filers with a current declared position in the same SPACs

Co-occurrence in the disclosure record, and nothing more. It is not evidence of a group, an agreement or acting in concert — filers who act as a group say so on the cover page and file a 13D. Two arbitrage funds above 5% in the same shell is the ordinary shape of this market. The second number restricts both sides to statements filed in the last 12 months, because a 2021 stake beside a 2026 one is two facts about two different years.

Every percentage above is the one printed on the cover page of the filing cited beside it — a percentage of the shares outstanding on that date. A SPAC’s float collapses at each redemption, so two of these percentages are percentages of two different companies and they do not add. Rows are one per SPAC: where a joint schedule names several reporting persons, the largest single figure is shown rather than their sum, because a manager and the funds it advises beneficially own the same shares. Nothing on this page is derived from a 13F, a vendor holdings file or a press release. See how this is built.